BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10200345)

  • 1. Prevention of colonic preneoplastic lesions by the probiotic Lactobacillus acidophilus NCFMTM in F344 rats.
    Rao CV; Sanders ME; Indranie C; Simi B; Reddy BS
    Int J Oncol; 1999 May; 14(5):939-44. PubMed ID: 10200345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of colonic aberrant crypt foci and modulation of large bowel microbial activity by dietary coffee fiber, inulin and pectin.
    Rao CV; Chou D; Simi B; Ku H; Reddy BS
    Carcinogenesis; 1998 Oct; 19(10):1815-9. PubMed ID: 9806164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of Bifidobacterium longum cultures on the azoxymethane-induced aberrant crypt foci formation and fecal bacterial beta-glucuronidase.
    Kulkarni N; Reddy BS
    Proc Soc Exp Biol Med; 1994 Dec; 207(3):278-83. PubMed ID: 7800683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of caffeic acid esters on azoxymethane-induced biochemical changes and aberrant crypt foci formation in rat colon.
    Rao CV; Desai D; Simi B; Kulkarni N; Amin S; Reddy BS
    Cancer Res; 1993 Sep; 53(18):4182-8. PubMed ID: 8364913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary inulin suppresses azoxymethane-induced preneoplastic aberrant crypt foci in mature Fisher 344 rats.
    Verghese M; Rao DR; Chawan CB; Shackelford L
    J Nutr; 2002 Sep; 132(9):2804-8. PubMed ID: 12221249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dietary oligofructose and inulin on colonic preneoplastic aberrant crypt foci inhibition.
    Reddy BS; Hamid R; Rao CV
    Carcinogenesis; 1997 Jul; 18(7):1371-4. PubMed ID: 9230282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modifying effects of naturally occurring products on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats.
    Kawamori T; Tanaka T; Hara A; Yamahara J; Mori H
    Cancer Res; 1995 Mar; 55(6):1277-82. PubMed ID: 7882322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition by dietary curcumin of azoxymethane-induced ornithine decarboxylase, tyrosine protein kinase, arachidonic acid metabolism and aberrant crypt foci formation in the rat colon.
    Rao CV; Simi B; Reddy BS
    Carcinogenesis; 1993 Nov; 14(11):2219-25. PubMed ID: 8242846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low doses of beta-carotene and lutein inhibit AOM-induced rat colonic ACF formation but high doses augment ACF incidence.
    Raju J; Swamy MV; Cooma I; Patlolla JM; Pittman B; Reddy BS; Steele VE; Rao CV
    Int J Cancer; 2005 Feb; 113(5):798-802. PubMed ID: 15499611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diosgenin, a steroid saponin of Trigonella foenum graecum (Fenugreek), inhibits azoxymethane-induced aberrant crypt foci formation in F344 rats and induces apoptosis in HT-29 human colon cancer cells.
    Raju J; Patlolla JM; Swamy MV; Rao CV
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1392-8. PubMed ID: 15298963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of azoxymethane-induced rat colon aberrant crypt foci by dietary protocatechuic acid.
    Kawamori T; Tanaka T; Kojima T; Suzui M; Ohnishi M; Mori H
    Jpn J Cancer Res; 1994 Jul; 85(7):686-91. PubMed ID: 8071110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-carcinogenic properties of omeprazole against human colon cancer cells and azoxymethane-induced colonic aberrant crypt foci formation in rats.
    Patlolla JM; Zhang Y; Li Q; Steele VE; Rao CV
    Int J Oncol; 2012 Jan; 40(1):170-5. PubMed ID: 21956158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary folate protects against azoxymethane-induced aberrant crypt foci development and oxidative stress in rat colon.
    Al-Numair KS; Waly MI; Ali A; Essa MM; Farhat MF; Alsaif MA
    Exp Biol Med (Maywood); 2011 Sep; 236(9):1005-11. PubMed ID: 21768165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
    Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis.
    Reddy BS; Rao CV; Seibert K
    Cancer Res; 1996 Oct; 56(20):4566-9. PubMed ID: 8840961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrolysed inulin alleviates the azoxymethane-induced preneoplastic aberrant crypt foci by altering selected intestinal microbiota in Sprague-Dawley rats.
    Pattananandecha T; Sirilun S; Duangjitcharoen Y; Sivamaruthi BS; Suwannalert P; Peerajan S; Chaiyasut C
    Pharm Biol; 2016 Sep; 54(9):1596-605. PubMed ID: 26794346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor.
    Rao CV; Kawamori T; Hamid R; Reddy BS
    Carcinogenesis; 1999 Apr; 20(4):641-4. PubMed ID: 10223193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary inulin suppresses azoxymethane-induced aberrant crypt foci and colon tumors at the promotion stage in young Fisher 344 rats.
    Verghese M; Rao DR; Chawan CB; Williams LL; Shackelford L
    J Nutr; 2002 Sep; 132(9):2809-13. PubMed ID: 12221250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of organoselenium compounds for potential chemopreventive properties in colon carcinogenesis.
    Reddy BS; Upadhyaya P; Simi B; Rao CV
    Anticancer Res; 1994; 14(6B):2509-14. PubMed ID: 7872674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of amount and types of dietary fat on intestinal bacterial 7 alpha-dehydroxylase and phosphatidylinositol-specific phospholipase C and colonic mucosal diacylglycerol kinase and PKC activities during stages of colon tumor promotion.
    Reddy BS; Simi B; Patel N; Aliaga C; Rao CV
    Cancer Res; 1996 May; 56(10):2314-20. PubMed ID: 8625306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.